General Atlantic LLC Pharvaris N.V. Transaction History
General Atlantic LLC
- $2.96 Billion
- Q1 2025
A detailed history of General Atlantic LLC transactions in Pharvaris N.V. stock. As of the latest transaction made, General Atlantic LLC holds 7,531,252 shares of PHVS stock, worth $159 Million. This represents 3.99% of its overall portfolio holdings.
Number of Shares
7,531,252
Previous 7,531,252
-0.0%
Holding current value
$159 Million
Previous $144 Million
18.1%
% of portfolio
3.99%
Previous 5.17%
Shares
4 transactions
Others Institutions Holding PHVS
# of Institutions
51Shares Held
39.1MCall Options Held
0Put Options Held
0-
Foresite Capital Management Iv, LLC Larkspur, CA4.41MShares$93 Million85.48% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.29MShares$90.5 Million72.08% of portfolio
-
Viking Global Investors LP3.65MShares$77 Million0.19% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA3.3MShares$69.7 Million17.41% of portfolio
-
Vr Adviser, LLC New York, NY3.11MShares$65.6 Million11.8% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $712M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...